.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Union Health Minister JP Nadda and French President Emmanuel Macron recently inaugurated the Indo-French Centre for AI in Health (IF-CAIH) at AIIMS Delhi. This landmark move strengthens bilateral cooperation in AI in healthcare and emerging medical technologies. Therefore, the new centre aims to bridge the gap between clinical research and technological innovation. Additionally, the IF-CAIH builds on existing partnerships in digital health, human resources, and antimicrobial resistance.
President Macron emphasized the critical need for building sovereign computing capacity during the launch event. Furthermore, he noted that trusted AI systems must serve humanity while protecting children and cultural diversity. Consequently, both nations committed to developing domestic talent to avoid overdependence on foreign technologies. Specifically, the centre results from an MoU between AIIMS, Sorbonne University, and the Paris Brain Institute. Moreover, researchers from IIT Delhi will contribute to these interdisciplinary healthcare solutions.
The launch coincided with the RUSH 2026 forum, which brought together global scientific leaders in New Delhi. Specifically, one high-level session focused on the role of AI in brain health and global medical challenges. Overall, this partnership reflects a shared vision for ethical and inclusive innovation in medicine. Ultimately, the centre provides a robust platform for young innovators to explore clinical cross-border collaboration.
Q1: What is the primary objective of the Indo-French Centre for AI in Health?
The IF-CAIH is designed to advance AI-driven research, medical education, and clinical innovation. It addresses complex healthcare challenges through interdisciplinary collaboration between India and France.
Q2: Which institutions are collaborating on this AI healthcare project?
The initiative involves a joint partnership between AIIMS Delhi, Sorbonne University, and the Paris Brain Institute. Additionally, the Indian Institute of Technology (IIT) Delhi and other French institutions provide academic support.
Q3: How does the centre address ethical concerns in artificial intelligence?
The partnership focuses on building sovereign, trusted AI systems. It emphasizes algorithmic transparency to address bias, protect data privacy, and ensure linguistic and cultural diversity in health solutions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India and France launch the IF-CAIH at AIIMS Delhi to advance AI-driven medical research, clinical innovation, and brain health through bilateral cooperatio...
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
